Netherlands· NL-dc5bd4ab5215
Amvuttra 25mg, oplossing voor injectie in voorgevulde spuit
A vutrisiran product containing vutrisirannatrium, registered in Netherlands by Alnylam Netherlands B.V.. The same ATC class is registered in 14 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Vutrisiran is registered in 14 of 19 countries.
Countries holding a registration under ATC N07XX18 (vutrisiran), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Vutrisiran · ATC N07XX18
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of vutrisiran costs, country by country.
Normalised to the WHO defined daily dose (0.278 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Vutrisiran · price per daily dose (0.278 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1135.51
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- VUTRISIRANNATRIUM
- Manufacturer
- Alnylam Netherlands B.V.
- Country
- Netherlands (NL)
- ATC code
- N07XX18
- ATC class
- Vutrisiran
- Defined daily dose
- 0.278 mg, P
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/22/1681
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vutrisiran in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceAMVUTTRA 25 mg, solution injectable en seringue préremplieALNYLAM NETHERLANDS (PAYS-BAS)
- SpainAMVUTTRA 25 MG SOLUCION INYECTABLE EN JERINGA PRECARGADAAlnylam Netherlands B.V.
- SwitzerlandAmvuttra
- United KingdomAmvuttra 25mg/0.5ml solution for injection pre-filled syringesAlnylam UK Ltd
- IcelandAmvuttraAlnylam Netherlands B.V.
- PolandAmvuttraAlnylam Netherlands B.V.
- CanadaAMVUTTRAALNYLAM NETHERLANDS B.V.
- SwedenAmvuttra 25 mg Injektionsvätska, lösning i förfylld sprutaAlnylam Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Amvuttra
- Liechtenstein · Amvuttra
- Norway · Amvuttra
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f5069a53-7732-4d56-986b-f24d2997e999 GET /v1/drugs/f5069a53-7732-4d56-986b-f24d2997e999?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor injectie",
"route": "Subcutaan gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/amvuttra-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Vutrisiran",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp128937",
"excipients": [
"DINATRIUMWATERSTOFFOSFAAT 2-WATER (E 339)",
"FOSFORZUUR (E 338)",
"NATRIUMCHLORIDE",
"NATRIUMDIWATERSTOFFOSFAAT 2-WATER (E 339)",
"NATRIUMHYDROXIDE (E 524)",
"WATER VOOR INJECTIE"
],
"substances": [
"VUTRISIRANNATRIUM"
],
"leaflet_url": null,
"authorised_at": "2022/09/15",
"procedure_number": "EMEA/H/C/005852",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/22/1681",
"additional_monitoring": "N"
}See everything about vutrisiran.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.